Effect and Safety of Shihogyejitang for Drug Resistant Childhood Epilepsy
Table 4
Effects of clinical parameters on seizure outcomes.
3 months
6 months
12 months
Age at the onset of first seizure (months)
Responders
13.47 ± 16.85
16.96 ± 19.66
18.92 ± 17.57
Nonresponders
8.69 ± 7.27
7.71 ± 6.83
9.97 ± 13.24
value
0.615
0.146
0.051
Age at the start of the SGT (months)
Responders
35.81 ± 34.77
43.58 ± 38.22
40.42 ± 31.54
Nonresponders
28.71 ± 26.23
24.07 ± 23.35
31.62 ± 32.56
value
0.776
0.086
0.139
Treatment duration (months)
Responders
22.34 ± 26.37
26.62 ± 29.16
21.50 ± 17.66
Nonresponders
20.02 ± 26.39
16.35 ± 22.54
21.65 ± 28.29
value
0.970
0.356
0.382
Number of AEDs that had been tried
Responders
3.00 ± 1.05
3.05 ± 1.16
2.92 ± 1.00
Nonresponders
3.71 ± 1.21
3.38 ± 1.15
3.31 ± 1.18
value
0.030
0.228
0.313
Data are presented as the mean ± SD. Mann-Whitney tests were used for comparison between responders and nonresponders. Statistically significant at . SGT, Shihogyejitang; AED, antiepileptic drug.
